Roberto De Luca is the Head of Antibody Therapeutics at Philochem AG, a position held since 2021, after serving as a Senior Scientist from 2018 to 2021. Roberto earned a Bachelor of Science in Biology from ETH Zürich in 2013, followed by a Master of Science in Cell Biology in 2015 and two Doctor of Philosophy degrees in Pharmaceutical Sciences between 2015 and 2018.
This person is not in the org chart
This person is not in any teams
This person is not in any offices